Literature DB >> 18843791

Effect of recombinant Rv1009 protein on promoting the growth of Mycobacterium tuberculosis.

X Wu1, Y Yang, Y Han, J Zhang, Y Liang, H Li, B Li, L Wang.   

Abstract

AIMS: To determine whether resuscitation-promoting factor (RPF) from Mycobacterium tuberculosis can promote mycobacterial growth and shorten culture time. METHOD AND
RESULTS: We cloned, expressed and purified an RPF from M. tuberculosis, Rv1009 protein and subsequently studied the biological activity of the recombinant Rv1009 (rRv1009) in liquid and on solid media. Our results indicate that the molecular weight of rRv1009 protein expressed in Escherichia coli BL21 was approximately 39 kDa. At picomolar and micromolar concentrations, rRv1009 protein could increase the optical density of freeze-dried Mycobacterium bovis BCG three to fivefold in Middlebrook 7H9 medium, stimulate the growth of viable mycobacteria on solid medium, and shorten positive growth detection time of a small number of M. tuberculosis in BACTEC 960 medium.
CONCLUSIONS: The rRv1009 could promote proliferation of mycobacteria. It may be useful for culture of mycobacteria presented in clinical samples. SIGNIFICANCE AND IMPACT OF THE STUDY: rRv1009 protein can be used as a growth-promoting reagent of mycobacteria in the medium to shorten the time of culture.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18843791     DOI: 10.1111/j.1365-2672.2008.03850.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  12 in total

1.  Expression, purification, crystallization and preliminary X-ray crystallographic analysis of a major fragment of the resuscitation-promoting factor RpfB from Mycobacterium tuberculosis.

Authors:  Alessia Ruggiero; Flavia Squeglia; Luciano Pirone; Stefania Correale; Rita Berisio
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-12-24

2.  Resuscitation-Promoting Factors Are Required for Mycobacterium smegmatis Biofilm Formation.

Authors:  Christopher Ealand; Binayak Rimal; James Chang; Lethabo Mashigo; Melissa Chengalroyen; Lusanda Mapela; Germar Beukes; Edith Machowski; Sung Joon Kim; Bavesh Kana
Journal:  Appl Environ Microbiol       Date:  2018-08-17       Impact factor: 4.792

Review 3.  Mycobacterium tuberculosis: success through dormancy.

Authors:  Martin Gengenbacher; Stefan H E Kaufmann
Journal:  FEMS Microbiol Rev       Date:  2012-03-08       Impact factor: 16.408

Review 4.  The current status, challenges, and future developments of new tuberculosis vaccines.

Authors:  Wenping Gong; Yan Liang; Xueqiong Wu
Journal:  Hum Vaccin Immunother       Date:  2018-05-14       Impact factor: 3.452

5.  Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting.

Authors:  Novel N Chegou; Gillian F Black; Andre G Loxton; Kim Stanley; Paulin N Essone; Michel R Klein; Shreemanta K Parida; Stefan H E Kaufmann; T Mark Doherty; Annemieke H Friggen; Kees L Franken; Tom H Ottenhoff; Gerhard Walzl
Journal:  BMC Infect Dis       Date:  2012-01-20       Impact factor: 3.090

6.  Increase in Bacterial Colony Formation from a Permafrost Ice Wedge Dosed with a Tomitella biformata Recombinant Resuscitation-Promoting Factor Protein.

Authors:  Indun Dewi Puspita; Wataru Kitagawa; Yoichi Kamagata; Michiko Tanaka; Cindy H Nakatsu
Journal:  Microbes Environ       Date:  2015-04-04       Impact factor: 2.912

Review 7.  Are uncultivated bacteria really uncultivable?

Authors:  Indun Dewi Puspita; Yoichi Kamagata; Michiko Tanaka; Kozo Asano; Cindy H Nakatsu
Journal:  Microbes Environ       Date:  2012-10-10       Impact factor: 2.912

8.  Host cytokine responses induced after overnight stimulation with novel M. tuberculosis infection phase-dependent antigens show promise as diagnostic candidates for TB disease.

Authors:  Paulin N Essone; Novel N Chegou; Andre G Loxton; Kim Stanley; Magdalena Kriel; Gian van der Spuy; Kees L Franken; Tom H Ottenhoff; Gerhard Walzl
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

9.  Immunogenicity and therapeutic effects of a Mycobacterium tuberculosis rv2190c DNA vaccine in mice.

Authors:  Yan Liang; Xiaoyan Zhang; Xuejuan Bai; Li Xiao; Xiaomei Wang; Junxian Zhang; Yourong Yang; Jinying Song; Lan Wang; Xueqiong Wu
Journal:  BMC Immunol       Date:  2017-02-27       Impact factor: 3.615

Review 10.  Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis.

Authors:  Wenping Gong; Yan Liang; Xueqiong Wu
Journal:  Biomed Res Int       Date:  2020-01-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.